Thank you for visiting Sunsho Pharmaceutical’s website.
On the 21st of last month, Fuji City, along with the neighboring city of Fujinomiya in the Tokai region, entered the rainy season. This occurrence was approximately 15 days later than usual and 23 days later than the previous year. The rainy season is projected to conclude around the 20th of this month. With July fast approaching, so too does the hot summer and the climbing season for Mt. Fuji. The Fujinomiya route is expected to open on the 10th, and we encourage you to experience the climb of this sacred peak rather than merely observing from afar.
The global economy, as noted by the World Bank, is showing signs of stabilization four years after being impacted by the pandemic, conflicts, inflation, and financial tightening. Although growth is expected to be more moderate compared to pre COVID-19 levels, it is anticipated to be steady. Nonetheless, several risks persist, including the stagnation of the Chinese economy, worsening situations in the Middle East, and the uncertain impact of the upcoming U.S. presidential election in November.
In Japan, growth driven by domestic demand is expected to continue. Wage increases are improving household incomes, boosting personal consumption. Favorable revenue conditions due to a weak yen are likely to lead to continued expansion in corporate capital investments.
The environment surrounding our core domestic health food business remains challenging. Recently, the number of reported health issues related to "red koji (red yeast rice)" has increased, potentially undermining consumer trust in health supplements. The Consumer Affairs Agency's guidelines necessitate that we strengthen the management of health-related information and improve communication with consumers. Additionally, we are required to comply with the mandatory GMP standards for processing companies.
At Sunsho Pharmaceutical, we are committed to ensuring the safety of our manufacturing processes based on these guidelines and to provide safety and security from a consumer perspective. Our mission is to "become the best partner for all those involved with Sunsho Pharmaceutical," and we are dedicated to contributing to the healthcare of people worldwide. As a contract development and manufacturing company, we strive to be the best partner and deliver absolute safety and security to the consumers of our health products, thereby enhancing trust in the health industry. We humbly ask for your continued support.
July 1, 2024
Row Imamura, CEO